findmyKOL
Clinical trialNCT04354428TerminatedPhase 2/PHASE3Interventional

Treatment for COVID-19 in High-Risk Adult Outpatients

SponsorUniversity of WashingtonEnrollment289COVID-19SARS-CoV-2
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a randomized trial for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in high-risk adults not requiring hospital admission.The overarching goal of this study is to assess the effectiveness of interventions on the incidence of lower respiratory tract infection (LRTI) progression among high-risk adult outpatients with SARS-CoV-2 infection to inform public health control strategies.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Ruth M. Rothstein Core Center - Cook County Health

    Chicago, Illinois, United States

  • Tulane University

    New Orleans, Louisiana, United States

  • Boston University

    Boston, Massachusetts, United States

  • Suny Upstate Medical University

    Syracuse, New York, United States

  • Uw Virology Research Clinic

    Seattle, Washington, United States

  • University of Washington Coordinating Center

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Ascorbic acidAzithromycin →Folic acid →Hydroxychloroquine →Lopinavir →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
16 Apr 2020
Primary completion
3 Nov 2020
Completion
30 Nov 2020
Last update posted
8 Aug 2022
Registered enrollment
289
Registry id
NCT04354428
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.